Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ReShape Weightloss Inc.RSLS · Entity 137993 | Director · Chairman, President and CEO | April 18, 2018 | April 20, 2018 |
| Vyome Holdings, IncRSLS · Entity 1824 | Director | July 22, 2021 | September 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ReShape Weightloss Inc.
Report date April 18, 2018 · Filed April 20, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.65 · Expires 2028-04-18 | Direct | 4,164,281 |
Reported balance
After 2018-04-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-04-18 · Grant · Acquired 4,164,281 · Balance 4,164,281 F1: Subject to the employee's continued service, 25% of shares will vest on the one-year anniversary of April 18, 2018 and the remaining 75% of shares will vest in as nearly equal amounts as possible on the last day of the next 36 months thereafter. |
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 1,925 |
Reported balance
Holding disclosure · report date 2018-04-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,925 |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to the employee's continued service, 25% of shares will vest on the one-year anniversary of April 18, 2018 and the remaining 75% of shares will vest in as nearly equal amounts as possible on the last day of the next 36 months thereafter.
Vyome Holdings, Inc
Report date July 22, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 283,922 |
Ending reported balance
After 2021-09-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-07-22 · Grant · Acquired 483,922 · Balance 483,922 F1: These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan. Row 2 · 2021-09-10 · Sale · Disposed 200,000 · Balance 283,922 F2: A portion of these shares were sold to cover taxes in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
F2: A portion of these shares were sold to cover taxes in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2021 Filed Sep 17, 2021 22:37 UTC | Vyome Holdings, Inc RSLS · Entity 1824 | SaleCommon Stock, $0.001 par value per share | 200,000 | $2.99 | $598,000.00 |
DisclosureSEC source: 0001790300-21-000009 · primary_doc.xml · nonDerivative · entry 2 GLADNEY DAN W · CIK 0001224184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,922 F2 · kind: A portion of these shares were sold to cover taxes in connection with the vesting of restricted stock units. Read SEC document |
| July 22, 2021 Filed Sep 17, 2021 22:37 UTC | Vyome Holdings, Inc RSLS · Entity 1824 | GrantCommon Stock, $0.001 par value per share | 483,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001790300-21-000009 · primary_doc.xml · nonDerivative · entry 1 GLADNEY DAN W · CIK 0001224184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,922 F1 · shares: These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan. Read SEC document |
| April 18, 2018 Filed Apr 20, 2018 16:54 UTC | ReShape Weightloss Inc. RSLS · Entity 137993 | GrantStock Option (right to buy) · Derivative | 4,164,281 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001371217-18-000002 · primary_doc.xml · derivative · entry 2 GLADNEY DAN W · CIK 0001224184 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,164,281 Underlying: Common stock · 4,164,281 shares Expires 2028-04-18 F1 · derivative.exercise_date: Subject to the employee's continued service, 25% of shares will vest on the one-year anniversary of April 18, 2018 and the remaining 75% of shares will vest in as nearly equal amounts as possible on the last day of the next 36 months thereafter. Read SEC document |
| October 06, 2017 Filed Oct 12, 2017 18:10 UTC | ReShape Weightloss Inc. ETRM · Entity 137993 | GrantStock Option (right to buy) · Derivative | 662,975 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001686266-17-000016 · primary_doc.xml · derivative · entry 2 GLADNEY DAN W · CIK 0001224184 · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,975 Underlying: Common stock · 662,975 shares Expires 2027-10-06 F1 · derivative.exercise_date: Subject to the continued service of employee, 25% of shares will vest on one-year anniversary of October 6, 2017 and the remaining 75% of shares will vest in as nearly equal amounts as possible on the last day of each of the next 36 months thereafter. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 16:43 UTC | ReShape Weightloss Inc. ETRM · Entity 137993 | GrantStock Option (right to buy) · Derivative | 466,500 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001209191-17-009576 · doc4.xml · derivative · entry 3 GLADNEY DAN W · CIK 0001224184 · Director · Chrm, Pres & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,500 Underlying: Common Stock · 466,500 shares Expires 2027-02-08 F3 · derivative.exercise_date: Vests immediately as to 25% on the date noted and thereafter in cumulative installments of 1/36th per month. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.